Optiver Holding
TYRA icon

Optiver Holding’s Tyra Biosciences TYRA Stock Holding History

Optiver Holding’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.06K Sell
106
-22
-17% -$712 ﹤0.01% 1517
2025
Q4 		$3.37K Sell
128
-240
-65% -$4.41K ﹤0.01% 1676
2025
Q3 		$5.15K Buy
+368
New +$4.2K ﹤0.01% 1715

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Optiver Holding's TYRA Position: Q1 2026 in Review

Optiver Holding reduced its Tyra Biosciences (TYRA) stake by 17% in Q1 2026, selling an estimated $712 and leaving 106 shares worth $4.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

Optiver Holding first reported a position in TYRA in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.15K in Q3 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Optiver Holding held 106 shares of Tyra Biosciences worth $4.06K as of Q1 2026.
  • Optiver Holding sold 22 Tyra Biosciences shares in Q1 2026, an estimated $712.
  • Tyra Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1517 holding.
  • Optiver Holding first reported a position in Tyra Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Tyra Biosciences position peaked at $5.15K in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.